MedTrace Logo

Using of Extracorporeal Shockwave Therapy in Treatment Of Achilles Tendinopathy

NCT04376294 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-07-17

No results posted yet for this study

Summary

The purpose of this study was to determine the effect of extracorporeal Shock wave therapy (ESWT) on functional activity and pain in patients with Achilles tendinopathy

Conditions

  • Achilles Tendinopathy

Interventions

DEVICE

Extracorporeal Shockwave Therapy(ESWT)

Each session of Extracorporeal Shockwave Therapy(ESWT) consists of 2000 pulses with a pressure of 3 bars (equals an energy flux density of 0.1 mJ/mm²), and treatment frequency of 8 pulses/sec

OTHER

Eccentric training of the calf muscle:

The patients were asked to stand with all their body weight on the injured leg on a wooden step. From an upright body position and standing with all body weight on the forefoot, with the ankle joint in plantar flexion. The calf muscle is loaded by having the patient lower the affected limb down by dorsiflexion the ankle until the plantar aspect of the heel lay below the level of the step, and the ankle is in maximum dorsiflexion.

OTHER

Gastrocnemius, soleus, and hamstring stretch

Stretching every muscle for 30 seconds. Each stretch was performed 3 times (holding for 30 seconds and rest for 30 seconds). All these stretches were performed directly after the eccentric exercises twice/day for 7 days/week for weeks

Sponsors & Collaborators

  • Prof.Dr. Emad Samuel Boles Saweeres

    collaborator UNKNOWN

  • Prof.Dr Nadia Abdelazim fayaz

    collaborator UNKNOWN

  • Mr.Mohamed Nasser Kise Helmy

    collaborator UNKNOWN

  • Cairo University

    lead OTHER

Principal Investigators

  • Dr. Nasr A. Abdelkader, PhD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2018-12-31
Completion
2020-06-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04376294 on ClinicalTrials.gov